GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Entero Healthcare Solutions Ltd

Entero Healthcare Solutions: Q2 FY27 Standalone Net Profit at Rs. 191.44 Million

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 04 Nov 2026, 08:27 PM IST  ·  BSE ID: acedfc9e-6a33-4947-bf24-a4fecc23bc59
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its financial report showing a profit of Rs. 191.44 Million for the quarter.
🤖 AI Summary
  • Standalone revenue from operations for Q2 FY27 reached Rs. 1,145.71 Million.
  • Profit for Q2 FY27 was Rs. 191.44 Million, up from Rs. 56.96 Million in Q2 FY26.
  • Basic earnings per share for Q2 FY27 stood at Rs. 4.40, compared to Rs. 1.31 in Q2 FY26.
  • The Board noted the grant of 49,712 Employee Stock Options under the 2023 ESOP Plan.
  • Half-year FY27 standalone revenue from operations was Rs. 1,978.37 Million.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
1,145.71 Million
37.67%
Profit for the period (Q2 FY27)
191.44 Million
236.10%
Total Expenses (Q2 FY27)
1,123.34 Million
12.52%
Earnings per share - basic (Q2 FY27)
4.40 Rs.
235.88%
Revenue from operations (Half year FY27)
1,978.37 Million
21.69%
Profit for the period (Half year FY27)
226.01 Million
78.62%
🏢 How This Affects the Company
📈
Business Impact
The growth in revenue from operations suggests an expansion in the company's core business activities of trading pharmaceutical and surgical products.
💰
Financial Impact
Net profit increased significantly on a year-over-year basis, which enhances the company's profitability metrics and can improve retained earnings.
⚙️
Operational Impact
The grant of Employee Stock Options indicates a continued focus on employee retention and incentivization, potentially impacting workforce motivation.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are indirectly affected by the company's financial performance, which shows increased profit and revenue. The grant of 49,712 Employee Stock Options will dilute existing shareholding marginally upon exercise.
🔍
Management Signal
The Board's approval of the unaudited results and noting the ESOP grant signals a focus on both financial performance transparency and employee incentivization.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — observe sustained revenue and profit growth.
Updates on ESOP exercises — track potential equity dilution from new grants.
Future subscription to Optionally Convertible Debentures by subsidiaries.
MEDIUM RISK Rising finance costs and other expenses warrant monitoring despite revenue growth.
💡 Investor Takeaway
Entero Healthcare Solutions reported Q2 FY27 standalone revenue from operations at Rs. 1,145.71 Million, a 37.67% increase YoY. Net profit for the period rose to Rs. 191.44 Million, up 236.10% from Rs. 56.96 Million in Q2 FY26, with basic EPS of Rs. 4.40.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 standalone profit for the period significantly increased to Rs. 191.44 Million from Rs. 56.96 Million in Q2 FY26.
  • Revenue from operations grew to Rs. 1,145.71 Million in Q2 FY27 from Rs. 832.21 Million in Q2 FY26.

⚠️ Concerns

  • Total expenses for Q2 FY27 were Rs. 1,123.34 Million, representing a rise from Rs. 998.37 Million in Q2 FY26.
  • Finance costs increased to Rs. 61.11 Million in Q2 FY27 from Rs. 7.11 Million in Q2 FY26.
📅 Company Track Record
Entero Healthcare Solutions Limited was incorporated in 2018. This is the first financial results filing found for the company, therefore, detailed historical trend analysis is not available.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Entero Healthcare Solutions' standalone net profit for Q2 FY27?
Entero Healthcare Solutions reported a standalone net profit for the period of Rs. 191.44 Million for the quarter ended 30 September 2026 (Q2 FY27).
What was Entero Healthcare Solutions' standalone revenue from operations in Q2 FY27?
The standalone revenue from operations for Entero Healthcare Solutions in Q2 FY27 was Rs. 1,145.71 Million.
How many Employee Stock Options were granted by Entero Healthcare Solutions?
The Board noted the grant of 49,712 Employee Stock Options under the existing “Entero Employee Stock Option Plan 2023”.
What were the basic earnings per share for Entero Healthcare Solutions in Q2 FY27?
The basic earnings per share for Entero Healthcare Solutions was Rs. 4.40 for the quarter ended 30 September 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.